Guardrisk Insurance Company Limited v Registrar of Medical Schemes

The appellant, Guardrisk Insurance Company Limited, is a registered short-term insurer in terms of the Short Term Insurance Act 53 of 1998 (STI Act). The respondents (Registrar and Council for Medical Schemes) obtained an interdict in the Johannesburg High Court preventing the appellant from marketing and selling two insurance policies named AdmedGap and AdmedPulse. These policies insured against hospital confinement and medical procedures, providing benefits calculated as the difference between the cost of medical services and the National Health Reference Price List (NHRPL) rates, limited to three and a half times NHRPL rates with specified annual maximums. Benefits were paid directly to the insured. The respondents contended that selling these policies constituted conducting the 'business of a medical scheme' without proper registration under the Medical Schemes Act 131 of 1998 (MS Act), which is prohibited. The appellant argued that its activities fell within the scope of an 'accident and health policy' under the STI Act and did not constitute the business of a medical scheme.

• Whether the marketing and sale of the AdmedGap and AdmedPulse policies constituted the 'business of a medical scheme' as defined in section 1 of the Medical Schemes Act 131 of 1998
• Whether the policies fell within the definition of 'accident and health policy' under the Short Term Insurance Act 53 of 1998
• Whether the words 'and' and 'or' in the relevant statutory definitions should be read conjunctively or disjunctively
• Whether there is a conflict between the MS Act and the STI Act in relation to these insurance products
• Whether the policies undermined the purpose and objectives of the Medical Schemes Act

The appeal was upheld with costs, including the costs of two counsel. The order of the court below was replaced with an order dismissing the application with costs, including the costs of two counsel. This meant that Guardrisk Insurance Company Limited was permitted to continue marketing and selling the AdmedGap and AdmedPulse policies.

The binding legal principle is that in statutory interpretation, the words 'and' and 'or' must be given their ordinary, literal meaning unless there are compelling reasons to deviate from this approach. When interpreting the definition of 'business of a medical scheme' in section 1 of the Medical Schemes Act 131 of 1998, the subsections (a) and (b) must be read conjunctively (and subsection (c) where applicable), meaning an entity must undertake liability in return for premium or contribution for all these elements to be conducting the business of a medical scheme. Similarly, in the definition of 'accident and health policy' in the Short Term Insurance Act 53 of 1998, the exclusions in subsection (d) must be read conjunctively - all three subparagraphs must be present for a contract to fall within the exclusion. Insurance policies that pay benefits as a stated sum of money to the insured (rather than to service providers) and do not meet all the conjunctive requirements of the exclusions fall within the permissible scope of accident and health policies under the STI Act and do not constitute the business of a medical scheme. The principle from Chotabhai applies: every part of a statute should be construed to be consistent with every other part and with other unrepealed statutes enacted by the same Legislature.

The court observed that the Medical Schemes Act fundamentally changed the operation of medical schemes by making membership and access to core health and medical services accessible to a broader spectrum of people through prohibitions on discrimination based on age, sex and health status, with differentiation only permitted on the basis of income and number of dependants. The court noted that practical reality has shown a need for gap coverage insurance products of the type offered by the appellant, and there seemed to be no reason why such products should not be permitted. The court also noted that although the STI Act does not contain a provision similar to section 29(1)(n) of the MS Act, short-term insurers are nonetheless obliged not to unfairly discriminate under sections 9(3) and (4) of the Constitution. The court commented that there was no factual indication that the appellant's policies were undermining or would undermine the MS Act or affect the viability of medical schemes in general, rejecting the respondents' purposive arguments in the absence of supporting evidence.

This case is significant in South African insurance and regulatory law as it clarifies the boundary between short-term insurance products and the business of medical schemes. It establishes important principles of statutory interpretation regarding the meaning of 'and' and 'or' in statutory definitions, confirming that these words should be given their ordinary, literal meaning unless compelling reasons exist to deviate. The judgment demonstrates how different regulatory regimes (short-term insurance and medical schemes) can operate compatibly without conflict when statutes are properly interpreted. It also recognizes the legitimacy of gap coverage insurance products that supplement medical scheme benefits, allowing innovation in the insurance market while maintaining the regulatory framework for medical schemes. The case has practical implications for the insurance industry in developing products that meet consumer needs without transgressing medical scheme regulations.